CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer
Ming Li, Shanglin Li, Ruocong Zhao, Jiang Lv, Diwei Zheng, Le Qin, Siyu Li, Qiting Wu, Youguo Long, Zhaoyang Tang, Yan‐Lai Tang, Lihua Yang, Yao Yao, Xue‐Qun Luo, Peng Li
Topics & Concepts
Chimeric antigen receptorCancer researchCytotoxic T cellCytotoxicityColorectal cancerAntigenCD28CancerCytokineImmunologyBiologyMedicineIn vitroImmunotherapyInternal medicineCD8BiochemistryCAR-T cell therapy researchImmune Cell Function and InteractionImmunotherapy and Immune Responses